Loading market quotes…

Subscribe free
Wall Street Radar3 minFreeGBC Research

AMPX (Amprius Technologies): stock research | Radar 17

Volume 17: Small & Mid-Caps Take the Q4 Crown

Our proprietary market health indicators maintain a bullish stance across all major indices, though prudent risk management suggests maintaining vigilance for potential market adjustments.

(please check our Market Monitor for additional information)

We’re excited to introduce two essential tools to enhance your market analysis: the T2108 and T2118 indicators. T2108 measures the percentage of NYSE stocks trading above their 40-day moving average. T2118 is the McClellan Summation Index, a cumulative measure of the McClellan Oscillator. We read it alongside the VIX when assessing exposure. For example, the current T2118 value is high but not overextended, suggesting you can cautiously add exposure. However, a pullback in 1-2 weeks is possible, so it’s wise to remain measured. Together, these tools provide a sharper edge for navigating market conditions.

From the next week, we will start to provide a short comment for both, to provide additional value to our subscribers.

AMPX (Amprius Technologies): stock research | Radar 17 · figure 1
AMPX (Amprius Technologies): stock research | Radar 17 · figure 2

Portfolio updates and new positions:

This week the only position we added was TSSI.

We reduced a little bit of DIS, LMND, and LLY.

AMPX (Amprius Technologies): stock research | Radar 17 · figure 3
AMPX (Amprius Technologies): stock research | Radar 17 · figure 4

🎢 High-Volatility Thrill Rides

AMPX: Amprius Technologies Inc

What they do: Next-generation battery technology developer.

Why watch? ⚡ Impressive post-earnings momentum despite being pre-profitable. Technical setup shows strong support confluence at 200 EMA, 10 EMA, and 20 EMA following a 120% surge. The key technical target at $2.68 represents a significant weekly and monthly resistance level. Volume consolidation pattern suggests healthy digestion of recent gains.

AMPX (Amprius Technologies): stock research | Radar 17 · 🎢 High-Volatility Thrill Rides · figure 5

ZBIO: Zenas Biopharma Inc

What they do: Innovative biopharmaceutical company (Recent IPO).

Why watch? 🧬 Experiencing significant institutional and insider accumulation between $15-17 despite sector-wide pressure. The critical technical junction at the $12.00 level could determine the next directional move. Pattern development suggests a potential bear trap versus breakout scenario.

AMPX (Amprius Technologies): stock research | Radar 17 · 🎢 High-Volatility Thrill Rides · figure 6

🏄‍♂️ Medium-Risk Wave Riders

MDGL: Madrigal Pharmaceuticals Inc

What they do: Pharmaceutical company focused on NASH treatments.

Why watch? 💊 Stellar 23% surge following Rezdiffra drug success. Technical formation showing bullish inverse head & shoulders pattern coupled with falling wedge consolidation on decreasing volume.

AMPX (Amprius Technologies): stock research | Radar 17 · 🏄‍♂️ Medium-Risk Wave Riders · figure 7

TLN: Talen Energy Corp

What they do: Energy sector leader.

Why watch? ⚡ Demonstrating exceptional strength in 2024's top-performing sector. Approaching critical breakout level at $221 (all-time highs).

AMPX (Amprius Technologies): stock research | Radar 17 · 🏄‍♂️ Medium-Risk Wave Riders · figure 8

AMTM: Amentum Holdings Inc

What they do: Space, robotics, and nuclear waste treatment solutions.

Why watch? 🚀 Recent IPO with upcoming catalyst (December 17 earnings). Key technical support at $23.50 could springboard the next upward movement.

AMPX (Amprius Technologies): stock research | Radar 17 · 🏄‍♂️ Medium-Risk Wave Riders · figure 9

DSP: Viant Technology Inc

What they do: Digital advertising technology platform.

Why watch? 📱 Recent Disney collaboration and strong earnings catalyst driving momentum. Healthy low-volume consolidation with 10 EMA convergence suggests optimal technical setup.

AMPX (Amprius Technologies): stock research | Radar 17 · 🏄‍♂️ Medium-Risk Wave Riders · figure 10

CVRX: CVRx Inc

What they do: Neuromodulation solutions for cardiovascular diseases.

Why watch? ❤️ Strong earnings momentum coupled with bullish cup & handle pattern formation. Technical support at 10 EMA with 20 EMA convergence. The key breakout level at $16 could trigger the next leg higher.

AMPX (Amprius Technologies): stock research | Radar 17 · 🏄‍♂️ Medium-Risk Wave Riders · figure 11

NTRA: Natera Inc

What they do: Genetic testing and diagnostics company.

Why watch? 🧬 Institutional favorite (Druckenmiller holding) showing 80%+ quarterly growth. Low-volume consolidation following a record-breaking quarter suggests healthy price digestion.

AMPX (Amprius Technologies): stock research | Radar 17 · 🏄‍♂️ Medium-Risk Wave Riders · figure 12

🛡️ Low-Risk Safe Harbors

ALB: Albemarle Corp

What they do: Global leader in lithium production.

Why watch? 🔋 Strategic symmetrical triangle formation with decreasing volume suggests an imminent move. Critical monthly support at $110 represents a potential launching pad for significant upside movement.

AMPX (Amprius Technologies): stock research | Radar 17 · 🛡️ Low-Risk Safe Harbors · figure 13

UTI: Universal Technical Institute Inc

What they do: Technical education provider.

Why watch? 📚 Overextended but maintaining momentum with high volume support. Recent earnings and revenue beats provide fundamental backing. Additional consolidation could improve risk/reward setup.

AMPX (Amprius Technologies): stock research | Radar 17 · 🛡️ Low-Risk Safe Harbors · figure 14

ESTC: Elastic N.V

What they do: AI-enabled search and data analytics platform.

Why watch? 🤖 Recent earnings beat and analyst upgrades highlight AI sector potential. Low-volume flag pattern developing with key breakout level at $112.

AMPX (Amprius Technologies): stock research | Radar 17 · 🛡️ Low-Risk Safe Harbors · figure 15

RAMP: LiveRamp Holdings Inc

What they do: Data connectivity platform.

Why watch? 📊 Comparable to APP with strong recent growth metrics. Completing major cup formation since August with technically constructive handle development on decreasing volume.

AMPX (Amprius Technologies): stock research | Radar 17 · 🛡️ Low-Risk Safe Harbors · figure 16

MCK: McKesson Corporation

What they do: Healthcare services and medical supplies distributor.

Why watch? 🏥 Record revenue performance with low-volume consolidation near $631 monthly resistance (all-time highs). The technical setup suggests imminent breakout potential.

AMPX (Amprius Technologies): stock research | Radar 17 · 🛡️ Low-Risk Safe Harbors · figure 17

"In investing, what is comfortable is rarely profitable."

Robert Arnott

AMPX (Amprius Technologies): stock research | Radar 17 · 🛡️ Low-Risk Safe Harbors · figure 18

Be the Force Behind Market Mastery - Support Our Community

Your contribution enables us to keep delivering premium market insights at no cost to thousands of investors

Disclaimer: This analysis is for informational purposes only and should not be considered as financial advice. Always conduct your research and consult with a licensed financial advisor before making investment decisions.

Newsletter

This piece was free. The next one lands on Sunday.

Every Sunday, we analyze up to ten stocks and publish our market view. A subscription includes the full research, price levels and our live positions in the chat. The free section arrives by email.

Related research
LTBR (Lightbridge): stock research | Radar 18Wall Street Radar · 08.12.2024NXL (Nexalin Technology): stock research | Radar 16Wall Street Radar · 24.11.20242026 investment themes: space, AI and infrastructure | X-Ray 29Equity X-Ray · 31.12.2025Baidu (BIDU), tariffs and trade-war risk | Radar 70Wall Street Radar · 18.01.2026MIND (Mind Technology): stock research | Radar 21Wall Street Radar · 29.12.2024 Full archive →
FREE · EVERY SUNDAY

Get the next Radar
before Monday’s open.

The first name, the reasoning, and our public research.

FREE · EVERY SUNDAYGet the watchlist